Quoin Pharmaceuticals Ltd DRC
Save
700.83K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.

Similar securities

Based on sector and market capitalization

Report issue